In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...

In a new study aimed at identifying the best approach to promote colorectal cancer screening in adults aged 45 to 49, UCLA researchers found that simply mailing a stool-based test directly to people's ...

New blood-based screening tests for colorectal cancer (CRC) offered fewer benefits at higher cost versus other screening options, a cost-effectiveness modeling study suggested. In a comparison against ...

Share on Pinterest New colorectal cancer guidelines from the ACS highlight noninvasive screening methods. Image credit: Marco Govel/Stocksy The American Cancer Society (ACS) updated its colorectal ...

Guidelines suggest colorectal cancer screening for average-risk people beginning at age 45. New colorectal cancer screening recommendations, released today by the American Cancer Society, may help ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of Shield Across America, a historic coast-to-coast mobile ...

Strategic collaboration to enable streamlined and accelerated access to Shield blood-based colorectal cancer screening test across Quest’s vast network Physicians nationwide now have the ability to ...

Colorectal cancer (CRC) is the second most common cause of cancer death in the United States and disproportionately impacts people who receive care in under-resourced settings. Fortunately, several ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...